Published in Emerg Microbes Infect on May 10, 2017
The rapid generation of mutation data matrices from protein sequences. Comput Appl Biosci (1992) 44.38
The global distribution and burden of dengue. Nature (2013) 27.92
Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics (2012) 26.90
Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med (2009) 17.89
MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. Mol Biol Evol (2016) 14.16
Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg (1952) 13.73
Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis (2008) 12.72
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis (2000) 11.44
Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet (2016) 10.08
Zika Virus Associated with Microcephaly. N Engl J Med (2016) 9.03
Zika virus, French polynesia, South pacific, 2013. Emerg Infect Dis (2014) 6.75
First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz (2015) 6.24
Zika Virus and Birth Defects--Reviewing the Evidence for Causality. N Engl J Med (2016) 6.01
Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013. Euro Surveill (2014) 5.65
Zika Virus Outbreak, Bahia, Brazil. Emerg Infect Dis (2015) 5.64
Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis (2016) 5.40
Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res (2003) 4.90
Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg (1989) 4.79
Cross-reacting antibodies enhance dengue virus infection in humans. Science (2010) 4.63
ZIKA VIRUS INFECTION IN MAN. Trans R Soc Trop Med Hyg (1964) 4.01
Zika virus, a cause of fever in Central Java, Indonesia. Trans R Soc Trop Med Hyg (1981) 3.72
Zika virus. II. Pathogenicity and physical properties. Trans R Soc Trop Med Hyg (1952) 3.56
The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe (2010) 3.48
Zika Virus. Clin Microbiol Rev (2016) 3.34
Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities. N Engl J Med (2016) 3.25
Notes from the Field: Evidence of Zika Virus Infection in Brain and Placental Tissues from Two Congenitally Infected Newborns and Two Fetal Losses - Brazil, 2015. MMWR Morb Mortal Wkly Rep (2016) 3.05
Arthropod-borne viral infections of man in Nigeria, 1964-1970. Ann Trop Med Parasitol (1975) 2.98
Concurrent outbreaks of dengue, chikungunya and Zika virus infections - an unprecedented epidemic wave of mosquito-borne viruses in the Pacific 2012-2014. Euro Surveill (2014) 2.91
Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J Virol (2007) 2.89
Zika virus infections in Nigeria: virological and seroepidemiological investigations in Oyo State. J Hyg (Lond) (1979) 2.77
Zika virus in Brazil and macular atrophy in a child with microcephaly. Lancet (2016) 2.64
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science (2016) 2.53
Emerging arboviruses in the Pacific. Lancet (2014) 2.48
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc Natl Acad Sci U S A (2012) 2.42
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol (2014) 2.34
Ocular Findings in Infants With Microcephaly Associated With Presumed Zika Virus Congenital Infection in Salvador, Brazil. JAMA Ophthalmol (2016) 2.34
Outbreak of Exanthematous Illness Associated with Zika, Chikungunya, and Dengue Viruses, Salvador, Brazil. Emerg Infect Dis (2015) 2.33
Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. Virology (2009) 2.26
Increase in Reported Prevalence of Microcephaly in Infants Born to Women Living in Areas with Confirmed Zika Virus Transmission During the First Trimester of Pregnancy - Brazil, 2015. MMWR Morb Mortal Wkly Rep (2016) 2.09
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol (2016) 2.08
The 3.8 Å resolution cryo-EM structure of Zika virus. Science (2016) 2.07
The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. PLoS Pathog (2010) 2.03
The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci Transl Med (2012) 1.95
Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature (2015) 1.72
DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers. Science (2015) 1.70
An in-depth analysis of original antigenic sin in dengue virus infection. J Virol (2010) 1.63
The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis (2016) 1.62
Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature (2016) 1.52
Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection. J Virol (2011) 1.51
Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody. Cell Host Microbe (2016) 1.41
Dengue in the Pacific--an update of the current situation. Pac Health Dialog (2005) 1.35
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci U S A (2016) 1.31
Seroprevalence of arboviruses among blood donors in French Polynesia, 2011-2013. Int J Infect Dis (2015) 1.28
Structural Basis of Zika Virus-Specific Antibody Protection. Cell (2016) 1.27
Zika virus: history of a newly emerging arbovirus. Lancet Infect Dis (2016) 1.20
A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins. Nat Commun (2015) 1.18
Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology. Viral Immunol (2010) 1.14
Local Mosquito-Borne Transmission of Zika Virus - Miami-Dade and Broward Counties, Florida, June-August 2016. MMWR Morb Mortal Wkly Rep (2016) 1.11
Recent emergence of dengue virus serotype 4 in French Polynesia results from multiple introductions from other South Pacific Islands. PLoS One (2011) 1.10
Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes. J Immunol (2012) 1.06
Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus. MBio (2016) 1.06
Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature (2016) 1.04
B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts. J Virol (2016) 1.00
Genomic characterization and phylogenetic analysis of Zika virus circulating in the Americas. Infect Genet Evol (2016) 0.86
An outbreak of dengue fever in Yap State. Pac Health Dialog (2005) 0.86
Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus. Sci Transl Med (2016) 0.84
Analysis of human monoclonal antibodies generated by dengue virus-specific memory B cells. Viral Immunol (2012) 0.84
Structure of the immature Zika virus at 9 Å resolution. Nat Struct Mol Biol (2017) 0.80